Interaction Between Exercise Intensity and Sedentary Behavior on VO2max Change in Patients with De Novo Parkinson Disease: The Study in Parkinson Disease of Exercise (SPARX) Phase 2 Randomized Clinical Trial
Study Design & Technical Specifications
Sample Size / Cohort
Documented in primary study
Subject / Study Model
CNS Experimental / Clinical Model
Analytical Modalities
Primary Abstract & Repository Description
Source: medRxiv (Neurology)Editorial Critique, Methodological Value & Reusability Guide
1. Scientific Context & Premise
This resource from medRxiv (Neurology) ("Interaction Between Exercise Intensity and Sedentary Behavior on VO2max Change in Patients with De Novo Parkinson Disease: The Study in Parkinson Disease of Exercise (SPARX) Phase 2 Randomized Clinical Trial") addresses critical scientific questions within Parkinson's Disease (PD). Research in this domain currently faces major translational bottlenecks, including quantifying prodromal alpha-synuclein pathology, dopaminergic nigrostriatal circuit vulnerability, and non-motor progression heterogeneity. By focusing on key thematic elements (medRxiv Clinical, Clinical Neurology, neurology, PARKINSON), this work contributes empirical evidence toward understanding how molecular, cellular, or systems-level alterations relate to core disease pathways such as α-synuclein seed amplification assays (SAA), LRRK2/GBA1 variants, DAT-SPECT, and digital motor kinematics. Integrating these findings into the broader open science ecosystem helps reduce fragmentation across independent laboratories and accelerates hypothesis verification.
2. Study Architecture & Findings
Methodologically, this preprint integrates Clinical Neurology, Preprint Article within a CNS Experimental / Clinical Model framework (cohort/experimental samples documented in source protocol). Curated via medRxiv (Neurology) (DOI: 10.64898/2026.09.30.26364437), the analytical approach provides structured insights into Parkinson's Disease (PD) pathophysiology. Evaluating the reported outcomes alongside Clinical Neurology, Preprint Article technical specifications allows researchers to benchmark effect sizes, assay sensitivity, and experimental reproducibility against established reference cohorts.
3. Secondary Analysis & Reusability
Researchers and computational neuroscientists can reuse this resource across multiple secondary workflows: (1) Cross-Cohort Harmonization & Meta-Analysis — combining these Clinical Neurology, Preprint Article records with complementary repositories (such as OpenNeuro, DANDI, Agora, or Europe PMC) to increase statistical power; (2) Computational Benchmarking & Machine Learning — utilizing the documented features (medRxiv Clinical, Clinical Neurology, neurology, PARKINSON) as training, validation, or out-of-distribution test sets for predictive biomarker discovery in Parkinson's Disease (PD); and (3) Experimental Protocol Alignment — referencing the study design (CNS Experimental / Clinical Model, cohort/experimental samples documented in source protocol) to calibrate sample size calculations (power analysis) and endpoint selection for upcoming preclinical or clinical studies.
4. Methodological Caveats & Governance
Because this record is indexed as a preprint, its experimental conclusions have not yet completed formal journal peer review; downstream clinical or therapeutic decisions should await peer-reviewed validation. Specifically, when interpreting Clinical Neurology, Preprint Article results in Parkinson's Disease (PD), researchers must control for confounding variables (such as age, sex, post-mortem interval, scanner/instrument drift, or medication state) and verify compliance with open-access attribution requirements (cc_by_nc).
Data Access, Reproducibility & Analysis Starter Guide
FAIR Open Science & Clinical Metadata Verification Protocol
Quick Data Access & Structured Export
Open the primary repository directly or download structured metadata (JSON / CSV) in one click.
This resource is indexed under FAIR (Findable, Accessible, Interoperable, and Reusable) open-science metadata standards, enabling programmatic cross-referencing across Europe PMC, Semantic Scholar, ClinicalTrials.gov, and CNS Open Data.
Programmatic Data Retrieval (Python Starter Code & Recommended SDKs)
Python Quickstart: Query Europe PMC & Semantic Scholar Metadata
# Fetch structured bibliographic & open-access data via Europe PMC REST API
import urllib.request
import urllib.parse
import json
query = "DOI:\"10.64898/2026.09.30.26364437\""
url = f"https://www.ebi.ac.uk/europepmc/webservices/rest/search?query={urllib.parse.quote(query)}&format=json&resultType=core"
with urllib.request.urlopen(url, timeout=10) as response:
payload = json.loads(response.read().decode("utf-8"))
results = payload.get("resultList", {}).get("result", [])
if results:
record = results[0]
print("Title:", record.get("title"))
print("Journal / Source:", record.get("journalTitle") or record.get("bookOrReportDetails"))
print("Cited By Count:", record.get("citedByCount", 0))Standardized 4-Step Workflow & Governance Checklist
Standardized Acquisition & Preprocessing Workflow
1. Programmatic Metadata & Full-Text OA Retrieval
Query Europe PMC or Crossref REST APIs using the persistent DOI/URL to retrieve structured XML full text, supplementary tables, and grant links.
2. Study Design & Cohort Eligibility Screening
Extract sample size, inclusion/exclusion criteria, and primary outcome endpoints for systematic review (PRISMA) inclusion.
3. Data Availability & Supplementary Repository Linkage
Locate accession numbers (GEO, SRA, OpenNeuro, DANDI, Zenodo, Figshare) referenced in the Data Availability section.
4. Citation Graph & Replication Tracking
Monitor supporting and contrasting citations over time to verify whether key findings have been independently replicated.
Reproducibility & Governance Checklist
- Verify whether the source is a peer-reviewed journal publication or an unrefereed preprint before clinical citation.
- Check supplementary data licenses (CC-BY / CC0) when extracting figures or summary statistics for meta-analyses.
- Cross-reference NCT clinical trial identifiers when evaluating therapeutic efficacy or biomarker endpoints.
Tags & Modalities
Bibliometrics, Peer-Review Status & Citation Export
Cross-referenced via Semantic Scholar, Europe PMC & bioRxiv
1. Citation Metrics & Context Breakdown
Citation Context Breakdown
2. Peer-Review Validation & Revision History
Preprint Article (bioRxiv / medRxiv — Awaiting Peer Review)
This article is indexed as an unrefereed preprint. Our ingestion pipeline periodically queries Europe PMC and bioRxiv/medRxiv APIs to automatically link the final peer-reviewed journal DOI once published.
3. Standardized Academic Citation & BibTeX Export
Pae, B. J. et al. (2026). Interaction Between Exercise Intensity and Sedentary Behavior on VO2max Change in Patients with De Novo Parkinson Disease: The Study in Parkinson Disease of Exercise (SPARX) Phase 2 Randomized Clinical Trial. medRxiv (Neurology). https://doi.org/10.64898/2026.09.30.26364437
@article{j.2026medr,
title = {Interaction Between Exercise Intensity and Sedentary Behavior on VO2max Change in Patients with De Novo Parkinson Disease: The Study in Parkinson Disease of Exercise (SPARX) Phase 2 Randomized Clinical Trial},
author = {Pae, B. J. and Novak, T. S. and Griffith, G. J. and Patterson, C. G. and Hackney, M. E.},
year = {2026},
journal = {medRxiv (Neurology)},
howpublished = {\url{https://doi.org/10.64898/2026.09.30.26364437}},
doi = {10.64898/2026.09.30.26364437},
note = {CNS Open Data: parkinson}
}Related Parkinson's & Movement Research & Datasets
Explore All DatasetsDandiset 000026: Subthalamic Nucleus Local Field Potentials (LFP) and Beta-Band Dynamics in Parkinson’s Patients
High-density intraoperative and chronically implanted deep brain stimulation (DBS) electrode recordings during motor resting and movement states from 34 patients with idiopathic PD.
OpenNeuro ds003505: Dopaminergic Striato-Cortical Circuit Connectivity in Parkinson’s Disease during Motor Execution
This open-access 3T fMRI dataset evaluates striato-cortical circuit connectivity across 72 Parkinsonian patients and controls under levodopa ON vs. OFF states. Complete with behavioral logs, it offers foundational data for modeling dopaminergic network dynamics in motor execution.
Focal drug uncaging for the precise control of endogenous nicotinic receptors in behaving mice
Nicotinic acetylcholine receptors shape diverse brain functions, including reward, aversion, and pain, but dissecting their roles in vivo requires drug delivery with spatiotemporal precision that conventional pharmacology cannot provide. Here we establish in vivo photopharmacology of endogenous nico...
Peripheral immunoinflammatory markers and clinical correlations in Parkinson's disease patients carrying LRRK2 G2385R and R1628P variants
Peripheral inflammation in Parkinsons disease (PD) remains poorly characterised among carriers of Asian-prevalent LRRK2 G2385R and R1628P variants. We investigated plasma immunoinflammatory markers (i.e., IL-6, TNF-, CCL2, CX3CL1, CCL5, and VCAM-1) via multiplex immunoassay in 240 participants: PD-G...
Pharmacological Inhibition of mTORC1 Reduces Neural Death and Damage Volume After MCAO by Modulating Microglial Reactivity
Preclinical evaluation of novel mTORC1 inhibitors in neurodegenerative models demonstrating reduced neuroinflammation.
Continuous High-Frequency Smartwatch Sensor Telemetry Predicts Parkinson’s Motor Fluctuation Subtypes
A 24-month longitudinal cohort of 650 Parkinson’s patients monitored with wrist-worn IMU accelerometer arrays establishes automated machine learning scores correlating with MDS-UPDRS Part III subscores.
Related Data & Resources
Academic Research & Medical Information Disclaimer
This page provides structured scientific metadata, methodological critiques, and open-data reusability guidelines intended strictly for neuroscience researchers and data scientists. It does not constitute medical advice, clinical diagnosis, or treatment recommendations.
Was this resource helpful?
Help improve data curation by sharing your feedback.